UniSuper Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.97M Buy
44,045
+268
+0.6% +$17.9K 0.02% 381
2026
Q1
$2.75M Sell
43,777
-1,056
-2% -$73.5K 0.02% 386
2025
Q4
$2.98M Sell
44,833
-4,683
-9% -$303K 0.02% 374
2025
Q3
$3.33M Buy
49,516
+11,933
+32% +$944K 0.02% 370
2025
Q2
$3.28M Sell
37,583
-2,971
-7% -$233K 0.02% 339
2025
Q1
$2.77M Buy
40,554
+2,377
+6% +$194K 0.02% 366
2024
Q4
$2.97M Sell
38,177
-76,404
-67% -$5.66M 0.02% 344
2024
Q3
$7.68M Buy
114,581
+15,226
+15% +$1.25M 0.06% 180
2024
Q2
$11.3M Buy
99,355
+11,394
+13% +$1.44M 0.09% 139
2024
Q1
$12.2M Buy
87,961
+8,651
+11% +$1.09M 0.12% 125
2023
Q4
$9.84M Sell
79,310
-2,465
-3% -$252K 0.11% 135
2023
Q3
$7.63M Sell
81,775
-675
-0.8% -$76.1K 0.09% 149
2023
Q2
$10.6M Buy
+82,450
New +$9.97M 0.12% 128

Other funds holding DXCM

UniSuper Management's DXCM Position: Q2 2026 in Review

UniSuper Management increased its DexCom (DXCM) stake by 0.61% in Q2 2026, buying an estimated $17.9K and bringing the position to 44,045 shares worth $2.97M. The position accounts for 0.02% of the portfolio, ranked #381.

UniSuper Management first reported a position in DXCM in Q2 2023 and has held it in 13 quarters since. The position peaked at $12.2M in Q1 2024. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • UniSuper Management held 44,045 shares of DexCom worth $2.97M as of Q2 2026.
  • UniSuper Management bought 268 DexCom shares in Q2 2026, an estimated $17.9K.
  • DexCom made up 0.02% of UniSuper Management's portfolio in Q2 2026, its #381 holding.
  • UniSuper Management first reported a position in DexCom in Q2 2023 and has held it in 13 quarters since.
  • UniSuper Management's DexCom position peaked at $12.2M in Q1 2024.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on UniSuper Management's 13F filing for Q2 2026, filed 14 Aug 2026.